Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Heterologous Vaccination With an Vaxzevria (ChAdOx1-S) Prime and a Comirnaty (BNT162b2) Boost to Homolog Vaccination

NCT04907331 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04907331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Heterologous Vaccination With an Vaxzevria (ChAdOx1-S) Prime and a Comirnaty (BNT162b2) Boost to Homolog Vaccination
Lead sponsor
Medical University Innsbruck
Phase
Phase 2
Overall status
Unknown status
Start date
May 10, 2021
Completion date
December 30, 2021
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection